Navigation Links
Elekta Launches New Version of Monaco Treatment Planning System with Segment Shape Optimization
Date:9/19/2012

ATLANTA, Sept. 19, 2012 /PRNewswire/ -- Elekta recently announced the latest production release of its Monaco® treatment planning system, version 3.20, which offers customers improved VMAT planning and delivery support in addition to support for Elekta's Agility™* 160-leaf multi-leaf collimator. This release promises to create new workflow efficiencies through integrated plan approval and enhanced integration with MOSAIQ® Oncology Information System.

The new Segment Shape Optimization™ is driving improved dose conformity, plan quality and delivery efficiency through its proprietary approach to smoothing and clustering segments then optimizing beam weights and shapes. Powered by the Monte Carlo algorithm, the results are plans that improve sparing of organs-at-risk and dose conformality.

In addition, the release's new contouring tool, EZ Sketch, and Room's Eye View increase workflow efficiency. Support for Agility means that Monaco 3.20 users can achieve a new level of beam-shaping precision and delivery speed.

Staff at Kettering Medical Center (Dayton, Ohio) used a pilot version of Monaco 3.20.

"We have been using Monaco 3.20 clinically since June 2012," says Christopher Wennerstrom, MS, DABR, Medical Physicist at Kettering Medical Center. "It has consistently provided excellent tumor coverage while meeting our physicians' very strict OAR tolerances. The new Target Penalty cost function and segment shape optimizer allow us to treat more patients with VMAT than ever before, and even our most complex SBRT cases have extremely quick treatment times."

Monaco is a state-of-the-art IMRT, VMAT and SBRT planning solution that features innovative biological cost functions with multi-criterial constrained optimization, a powerful leaf sequence optimizer and a robust Monte Carlo dose calculation algorithm. Monaco helps make the planning process easier, more straightforward and clinically reliable.

For more information on Elekta's latest treatment planning releases, visit: www.elekta.com/rtp.

*Agility is not licensed for sale in all markets. Please contact your local representative for details.

For further information, please contact:
Johan Andersson Melbi, Investor Relations Manager, Elekta AB
Tel: +46 702 100 451, email: johan.anderssonmelbi@elekta.com  
Time zone: CET: Central European Time

Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: michelle.joiner@elekta.com 
Time zone: ET: Eastern Time

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.


'/>"/>
SOURCE Elekta
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta
2. Elekta to Demonstrate Latest MOSAIQ OIS Innovations for Oncology Practices at 2012 ASCO Annual Meeting
3. Elekta and The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital Sign Strategic Alliance to Further Cancer Research
4. Austrian Medical Center Upgrades Cancer Treatment System, Improves Patient Care with Elektas Agility Beam-shaping Device
5. U.K. Cancer Patient is Worlds First to Benefit from Treatment Combining Elektas New Beam-shaping Innovation and High-speed Arc Therapy
6. Elektas Gamma Knife and Radiation Therapy Systems for Cancer Treatment Take Top Three Places in 2012s Best in KLAS for Radiation Therapy
7. Elekta to Showcase Revolutionary Agility Beam-shaping Innovation at Radiation Physics Annual Meeting
8. Elekta Technology at Work in 100 Percent of Americas Top Cancer Hospitals
9. ASRT Foundation and Elekta Award More Than $20,000 in Scholarships to Radiation Therapy Students
10. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
11. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... United Kingdom and  BOSTON , March 28, ... Linguamatics today announced a partnership with ... The agreement allows pharmaceutical companies to extract key ... I2E text mining technology. The ... of the top 20 global pharmaceutical companies. The ...
(Date:3/28/2017)... March 28, 2017  CASI Pharmaceuticals, Inc. (Nasdaq: ... addressing cancer and other unmet medical needs, announced ... for Cancer Research annual meeting.  The first poster ... "Evaluation of ENMD-2076 in Combination with Anti-PD1 ... poster to be presented on April 4 is ...
(Date:3/28/2017)... CAMBRIDGE, England , March 28, 2017 ... in collaborative research with Cambridge ... Milner Therapeutics Consortium   The Milner Therapeutics Institute ... Therapeutics Consortium. Elysium Health has committed significant investment for collaborative ... over the next four years. This is the first major ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... , ... Alert Sentry Group LLC., a leader in the Personal Emergency Response ... and the iSAFE Plus. These iSAFE products are the most affordable and most advanced ... iSAFE Plus offer direct GPS Location and two-way calling with the push of a ...
(Date:3/28/2017)... Greifensee, Switzerland (PRWEB) , ... March 28, 2017 ... ... testing for laboratory instruments are critical to ensuring high-quality results and maintaining GMP ... and Qualification of Laboratory Instruments in accordance with GMP requirements " these requirements ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... measurement of corrosive ions found in power plant water and steam. , Chlorides ... as turbines and boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring these ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... will be offered by the American Association of Integrative Medicine and available for ... healthcare providers at the AutismOne 2017 Conference in Colorado Springs. , Ed Arranga, ...
(Date:3/28/2017)... ... , ... Silicon Valley Hair Institute, the San Francisco Bay Area leader in ... hair loss. Although hair transplant procedures can be seen as more of a man’s ... be two reasons a woman may see her hair thinning. , “We are used ...
Breaking Medicine News(10 mins):